Page last updated: 2024-12-08

jmv 449

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

JMV 449: amino acid sequence given in first source; a pseudopeptide analog of neurotensin (8-13) [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID164415
MeSH IDM0208815

Synonyms (17)

Synonym
gtpl1570
jmv449
jmv 449
139026-66-7
(2s)-2-[[(2s,3s)-2-[[(2s)-2-[[(2s)-1-[(2s)-6-amino-2-[[(2s)-2,6-diaminohexyl]amino]hexanoyl]pyrrolidine-2-carbonyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylpentanoyl]amino]-4-methylpentanoic acid
neuromedin n (pig spinal cord), 1-de-l-lysine-2-(n2-(2,6-diaminohexyl)-l-lysine)-, (s)-
h-lys-psi-(ch2nh)-lys-pro-tyr-ile-leu-oh
jmv-449
h-lysyl-psi(ch2nh)-lysyl-prolyl-tyrosyl-isoleucyl-leucine-oh
AKOS024456902
DTXSID10930283
n-(2-{[2-{[{1-[n~2~-(2,6-diaminohexyl)lysyl]pyrrolidin-2-yl}(hydroxy)methylidene]amino}-1-hydroxy-3-(4-hydroxyphenyl)propylidene]amino}-1-hydroxy-3-methylpentylidene)leucine
jmv 449 acetate
cid 164415
HY-P1256
l-leucine,n2-[(2s)-2,6-diaminohexyl]-l-lysyl-l-prolyl-l-tyrosyl-l-isoleucyl-
CS-0029131
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1346391Rat NTS1 receptor (Neurotensin receptors)2003Molecular pharmacology, Aug, Volume: 64, Issue:2
Differential involvement of intracellular domains of the rat NTS1 neurotensin receptor in coupling to G proteins: a molecular basis for agonist-directed trafficking of receptor stimulus.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (15)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's5 (33.33)18.2507
2000's5 (33.33)29.6817
2010's4 (26.67)24.3611
2020's1 (6.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other15 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]